International Society for the Study of Women's Sexual Health

NEWS

DYSPAREUNIA: CMS CLARIFICATION RESULTS IN EXPANDED TREATMENT AND COVERAGE UNDER MEDICARE PART D

ISSWSH is pleased to announce and recognize the Centers for Medicare and Medicaid Services (CMS) clarification of the statutory intent of “Prescription Drug Benefits” section 1860D-2(e)(2)(A) of the Social Security Act, stating that drugs for the treatment of moderate to severe dyspareunia (pain during sexual intercourse) due to menopause, are not excluded from Medicare Part D coverage when used consistent with this labeling.

ISSWSH, alongside the North American Menopause Society (NAMS), the American College of Obstetricians and Gynecologists (ACOG), and many other interested parties are committed to women’s health and particularly sexual health. James A. Simon, MD, President of ISSWSH, thanks these partners and commends CMS for this clarification that now allows women suffering from dyspareunia, to access expanded treatment options and get coverage under Medicare Part D.

View Press Release

Save the Date

ISSWSH / ISSM Joint Meeting 2019
March 7-10, 2019   43 days left
Atlanta, GA, USA
Read more...

ISSWSH Fall Course 2019
November 14-16, 2019   295 days left
DoubleTree Hilton Hotel, Scottsdale, AZ - USA
Read more...

ISSWSH Annual Meeting 2020
March 5-8, 2020   407 days left
Renaissance Orlando at Seaworld, Orlando, FL, USA

Latest Tweets

Have you purchased the ISSWSH Slide Deck? Meaningful information about female sexual health for the low costs of $3… https://t.co/xeXNxz9rvt ISSWSH
Care about #cancer #survivorship and #qualityof life? #ISSWSH2019 instructor Michelle Lyons is providing guidance… https://t.co/DOwNySNb1I ISSWSH
Will at home pap smears or STI test become a thing? a recent study in the Green Journal demonstrated the possible v… https://t.co/g4kJVW7ZAN ISSWSH

Contact Details

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville, MN 55306
USA

Phone: +1 (952) 683 9025
Fax: +1 (952) 314 8212
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Follow us on Twitter!